Novartis | NOVN - EPS Earnings Per Share


Novartis reported $2.46 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 2.46 2.04 Oct/27
FY2026Q2 Jun/2026 2.41 2.42 Jul/21
FY2026Q1 Mar/2026 1.99 2.28 Apr/28
FY2025Q4 Dec/2025 2.03 1.98 Apr/02
FY2025Q3 Sep/2025 2.04 1.58 Oct/28




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alcon AG USD 0.84 0.01 Jun/2026
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Autolus Therapeutics Ltd USD -0.15 0.12 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Fresenius EUR 0.83 0.01 Jun/2026
Fresenius Medical Care EUR 1.12 0.21 Jun/2026
Genmab DKK 5.43 4.6 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
J&J USD 2.7 0.2 Sep/2026
Lakefront Biotherapeutics EUR -0.2 0.64 Jun/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR -0.54 2.65 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 1.99 0.45 Mar/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Orion EUR 1 0.34 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Philips EUR 0.49 0.26 Jun/2026
Recordati EUR 0.65 0.08 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
UCB EUR 5.65 3.21 Dec/2025